Martin Driscoll

2019

In 2019, Martin Driscoll earned a total compensation of $1.4M as Former Chief Executive Officer at F-star Therapeutics.

Compensation breakdown

Bonus$61,875
Option Awards$364,334
Salary$495,000
Stock Awards$505,416
Other$11,200
Total$1,437,825

Driscoll received $505.4K in stock awards, accounting for 35% of the total pay in 2019.

Driscoll also received $61.9K in bonus, $364.3K in option awards, $495K in salary and $11.2K in other compensation.

Rankings

In 2019, Martin Driscoll's compensation ranked 7,519th out of 13,971 executives tracked by ExecPay. In other words, Driscoll earned more than 46.2% of executives.

ClassificationRankingPercentile
All
7,519
out of 13,971
46th
Division
Manufacturing
2,919
out of 5,701
49th
Major group
Chemicals And Allied Products
1,098
out of 2,200
50th
Industry group
Drugs
935
out of 1,886
50th
Industry
Pharmaceutical Preparations
691
out of 1,398
51st
Source: SEC filing on April 7, 2021.

Driscoll's colleagues

We found six more compensation records of executives who worked with Martin Driscoll at F-star Therapeutics in 2019.

2019

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2019

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

2019

RP Iyer

F-star Therapeutics

Chief Scientific Officer

2019

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2019

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

2019

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

News

You may also like